The latest CDC data available, updated Jan. 22, suggests Johnson & Johnson’s vaccine is slightly more protective than its mRNA counterparts. The data reveals unvaccinated people were 3.2 times as likely to contract COVID-19 as those who received Johnson & Johnson’s single-dose vaccine, whereas they were 2.8 times as likely to contract COVID-19 as those who received two doses of Moderna’s vaccine, and 2.4 times as likely as those who received two doses of Pfizer’s vaccine.
“This vaccine platform may have some surprising characteristics that we hadn’t anticipated.” Larry Corey, MD, a vaccine expert at the Fred Hutchinson Cancer Research Center in Seattle, told the Times. He said the new data is “interesting, provocative, and we should spend more time understanding it.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
